Position: Business Development Manager Location: Dublin / Hybrid Salary: Negotiable D.O.E The Job: The Business Development Manager will be part of a wider sales team, which as a group will be responsible for both proactive new busine...
Our client is currently seeking applications from ENT SHO's A fantastic opportunity to progress your career for a suitably qualified Senior House Officer Essential requirements: Registered with Irish Medical Council (IMC) Relevan...
Job Description A brand-new role just opened with a top client in Dublin. My client is looking for a SAP FICO Business Analyst to join their team on Perm basis. The successful candidate will be working on a SAP S/Hana BAU transformation...
We are recruiting for an Occupational Health Nurse for our client North Dublin Part-time role The ideal candidate will have Occupational Health experience and education but a qualification in Occupational Health is essential. Candidat...
against Turner & Townsend policy for candidates to pay any fee in relation to our recruitment process. No recruitment agency working... of agency fees. In order to be an authorised Recruitment Agency/Search Firm for Turner & Townsend, there must be a formal...
Marketing Manager Dublin South - Hybrid €65,000 with excellent benefits This is a great opportunity to join a new company with the security of a large group. We are hiring a Marketing Manager to develop and own the marketing strategy for th...
application or interview process may contact, in confidence, recruitment@esb.ie If you have any queries in relation... to this job, please contact recruitment@esb.ie Your application will be held in reserve for 6 months should you be suitable for the role....
The price control cap of 90% shall be applicable only to the SME segment and not for Mainboard IPOs, Relisted Securities or Public Debt, it added. Continue Reading »
Ambey Laboratories, with 40 years in agrochemicals, is offering IPO at ₹65-68 per share. The net proceeds will fund working capital needs and general business objectives. Continue Reading »
Bajaj Finance saw a record 4.47 million new customer additions in Q1FY25 and new loan bookings improved to 10% following the RBI's lift on loan restrictions. Despite this operational success, the stock has lagged. Are better days ahead for Bajaj Finance? Continue Reading »
Domestic brokerage firm Nuvama Professional Clients believes the stock has significant upside potential, citing the company's growth trajectory. It initiated coverage on the stock with a 'buy' rating on Wednesday, setting a target price of ₹757. Continue Reading »
Indian stock market surges post-elections despite concerns over inflation and interest rates. Sensex hits record high, Nifty 50 also peaks. Mid and smallcap segments outperform driven by economic growth and government policies. Continue Reading »
As markets continue their record-high momentum, industry experts share their perspectives on how investors should navigate the current market landscape. From sectoral preferences to prudent portfolio adjustments, their insights provide valuable guidance to investors. Continue Reading »